| Hasmik Rafaili Rubenyan, | |
|
8607 Santa Monica Blvd, West Hollywood, CA 90069-4109 | |
| (310) 659-9810 | |
| Not Available |
| Full Name | Hasmik Rafaili Rubenyan |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 8607 Santa Monica Blvd, West Hollywood, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285356501 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 22858 (Nevada) | Secondary |
| 183500000X | Pharmacist | 81438 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hasmik Rafaili Rubenyan, 6522 Columbus Ave, Van Nuys, CA 91411-1404 Ph: (323) 810-6053 | Hasmik Rafaili Rubenyan, 8607 Santa Monica Blvd, West Hollywood, CA 90069-4109 Ph: (310) 659-9810 |
News Archive
NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported that Nycomed, a global pharmaceutical company, headquartered in Switzerland, has submitted a Marketing Authorization Application to the European Medicines Agency for clearance to market teduglutide as a once-daily subcutaneous treatment for short bowel syndrome.
Your genes are blueprints for proteins, and molecules called microRNA can help to determine how often these genetic blueprints are manufactured into proteins. Researchers often ask what microRNA regulates a gene related to disease.
Anxiety and uncertainty can cause us to become more idealistic and more radical in our religious beliefs, according to new findings by York University researchers, published in this month's issue of the Journal of Personality and Social Psychology.
Researchers are getting closer to learning how to turn white fat cells into brown fat cells, in a process called "beiging," to bring down blood sugar levels and fight diabetes. The team, led by Joseph Baur, PhD, an assistant professor of Physiology in the Perelman School of Medicine at the University of Pennsylvania published their findings this month in the journal Diabetes.
The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.
› Verified 9 days ago
Richard Ludwig Pilsl, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 834 Huntley Dr, West Hollywood, CA 90069 Phone: 619-204-8642 | |
Van Benjamin Hau, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8607 Santa Monica Blvd, West Hollywood, CA 90069 Phone: 626-524-2951 | |
Dr. Jesse Ryan Wisniewski, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8700 Beverly Blvd, Room A903, West Hollywood, CA 90048 Phone: 310-423-5611 Fax: 310-423-0412 | |
Ms. Jill Kolin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7100 Santa Monica Blvd, West Hollywood, CA 90046 Phone: 323-603-0005 Fax: 323-603-0707 | |
Dr. Siamak Bagheri, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8737 Beverly Blvd, West Hollywood, CA 90048 Phone: 310-657-2881 | |
Edward A Bubar, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8500 Melrose Ave, #109, West Hollywood, CA 90069 Phone: 310-358-2400 Fax: 310-358-2410 | |
Dr. Andrea Saenz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8605 Santa Monica Blvd, West Hollywood, CA 90069 Phone: 855-472-2548 |